Skip to main content Back to Top
Advertisement

News and Press Releases

10/14/2014

Ebola Cases Bring Practical and Clinical Challenges

Caring for the first two Ebola virus–infected humanitarian workers in the United States required high-level clinical services for the patients as well as practical strategies to deal with fears among hospital staff and the local community. For hospital staff, twice-daily "town hall" meetings were

10/14/2014 Press Release

Pediatric Pharmacotherapy Self Assessment Book Now Available from ASHP

ASHP has published Pediatric Pharmacotherapy Self Assessment, authored by Sandra Benavides, Pharm.D.; Hanna Phan, Pharm.D., BCPS; and Milap C. Nahata, Pharm.D., M.S., to help pharmacists evaluate and improve their care of pediatric patients.   With little clinical data available on the efficacy

10/14/2014 Press Release

ASHP Publishes New Edition of Popular Handbook on Injectable Drugs

ASHP has released the 18th edition of its newly updated Handbook on Injectable Drugs™. With its 38-year track record, the Handbook is considered the “Gold Standard” for translating thorough, complex data on parenteral drugs into an essential resource that is easily accessible to busy practitioners w

10/1/2014

Medicare's Inpatient PPS Continues Focus on Quality, Value

With the start of a new federal fiscal year today, Medicare has underway three programs that can alter payments to an acute care hospital on the basis of past performance on measures of patient care, safety, and outcomes. The three programs, part of the Medicare hospital inpatient prospective paym

10/1/2014

ASHP Asks Genentech to Reconsider Distribution Change, Calls for Stakeholder Meeting

A planned change to the distribution system for bevacizumab, trastuzumab, and rituximab could adversely impact patient care, ASHP CEO Paul W. Abramowitz told Genentech CEO Ian T. Clark today. ASHP noted that the current supply chain effectively addresses patient care needs while providing for fina

9/19/2014

Dulaglutide Approved for Type 2 Diabetes

The glucagon-like peptide (GLP)-1 receptor agonist dulaglutide has been approved for the treatment of type 2 diabetes, FDA and Eli Lilly and Company announced September 18. Dulaglutide will be available later this year under the brand name Trulicity, Lilly stated. According to the labeling (PD

9/19/2014

Students Take to Capitol Hill for Provider Status

Fifteen pharmacy students answered ASHP's call to spend September 17 on Capitol Hill as part of a group advocating to grant pharmacists status as healthcare providers in the Medicare program. In all, 108 ASHP members visited 146 congressional offices during ASHP's annual Legislative Day. This yea

9/18/2014

Baxter Recalls Product Because of Incorrect Shipping Carton Label

Baxter International Inc. is recalling 100-mL potassium chloride injection lot P318220 because shipping cartons with this lot's label on the outside may actually have containers of gentamicin sulfate injection, according to a notice circulated today by FDA. The company's codes for the two products

Showing 1169-1176 of 2079

Prev
  • 147
  • OF 260
Next